Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals.
about
Statistical analysis of pharmacokinetic data.Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP).Population pharmacokinetic/pharmacodynamic assessment of pharmacological effect of a selective estrogen receptor β agonist on total testosterone in healthy men.Ondansetron pharmacokinetics in pregnant women and neonates: towards a new treatment for neonatal abstinence syndromeFactors influencing elimination and distribution of fleroxacin: metaanalysis of individual data from 10 pharmacokinetic studiesPopulation pharmacokinetics of platinum after nedaplatin administration and model validation in adult patients.The effect of sepsis upon gentamicin pharmacokinetics in neonates.Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.Fundamentals of population pharmacokinetic modelling: validation methods.Pharmacometric Modeling of Liver Metastases' Diameter, Volume, and Density and Their Relation to Clinical Outcome in Imatinib-Treated Patients With Gastrointestinal Stromal Tumors.Improving the estimation of parameter uncertainty distributions in nonlinear mixed effects models using sampling importance resamplingdOFV distributions: a new diagnostic for the adequacy of parameter uncertainty in nonlinear mixed-effects models applied to the bootstrap.Saturable rate of cefatrizine absorption after oral administration to humans.Population pharmacokinetics of acyclovir in children and young people with malignancy after administration of intravenous acyclovir or oral valacyclovir.Pharmacodynamic comparison of LY3023703, a novel microsomal prostaglandin e synthase 1 inhibitor, with celecoxib.
P2860
Q34051009-E8F6A28E-71EC-472F-B4FA-3F26537177C9Q34077383-35A038FC-C3DF-49E3-9FD5-4B0FDA7429EFQ34524636-7AC0CBE1-F724-46A8-A0C2-AA5C1E3DF3A9Q35075945-86422FA6-D5F9-46F2-AE78-CEE8C0410D7FQ35122861-D7343AF4-595F-4596-8592-8DEBD46CB8C7Q35825455-9CAB12AE-89C5-44DA-B2C8-531BEFC29E58Q35827298-89B706C0-B922-4FD3-8657-149ED2AD1854Q36747438-B8E6036E-42AD-4775-B166-301CCE67128CQ38026590-E2A89F6B-FD0D-4A81-9F7C-02D99850888AQ38852974-D5C19425-27B2-4183-84BF-E8ABAE17A4C5Q39300554-9B109134-D030-4D6A-9246-BC9ED5F33C80Q39300563-EE7B3D03-FB93-46DF-843D-D7A0C4159731Q41228295-40171C8D-5F90-4714-92FB-80A3EA6E3050Q42286838-11F65D61-8E4E-4467-AE22-EB9D8DEC0983Q47569669-3FBB50D6-721D-4B6F-BEE4-525EBB7E263D
P2860
Analysis of pharmacokinetic data using parametric models. III. Hypothesis tests and confidence intervals.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@ast
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@en
type
label
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@ast
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@en
prefLabel
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@ast
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@en
P2860
P356
P1476
Analysis of pharmacokinetic da ...... ests and confidence intervals.
@en
P2093
Sheiner LB
P2860
P2888
P304
P356
10.1007/BF01059660
P577
1986-10-01T00:00:00Z